CCR2 and metabolic dysfunction-associated steatotic liver disease: Our findings provide evidence that 2,5-DHBA ameliorates lipid accumulation in hepatocytes and in HFD-induced MASLD mice, likely through the modulation of the CCL2-CCR2 axis.